The first ever early clinical trial for a vaccine for genital chlamydia has shown it to be safe and effective at provoking an immune response.
The latest findings, from a randomised controlled trial of 35 healthy women led by Imperial College London and the Statens Serum Institut in Copenhagen, demonstrate promising early signs of what could be an effective vaccine against chlamydia.
The infection is the most common bacterial sexually transmitted infection (STI) worldwide and it can lead to infertility.
One of the problems we see is that people get repeatedly re-infected. If you could introduce a protective vaccine, you could break that cycle. Professor Robin Shattock Department of Infectious Disease
The researchers highlight that the work is an ‘important first step’ but add that further trials are now needed to determine whether the immune response provoked by the vaccine will effectively protect against chlamydia infection.
Professor Robin Shattock, Head of Mucosal Infection and Immunity within the Department of Infectious Disease at Imperial said: “The findings are encouraging as they show the vaccine is safe and produces the type of immune response that could potentially protect against chlamydia.
“The next step is to take the vaccine forward to further trials, but until that’s done, we won’t know whether it is truly protective or not.”
Most prevalent bacterial STI
Chlamydia trachomatis is one of the most prevalent bacterial STIs, representing a major global health burden, with 131 million new cases occurring each year. However, as many as 3 out of 4 infections are symptomless, so the number of cases is likely to be underestimated.
National screening programmes and antibiotic treatment have failed to reduce infection rates, and the highest number of new cases are found in teenagers and young adults.
While infection can often be treated with antibiotics, complications can include inflammation, infertility, ectopic pregnancy, arthritis and even an increased susceptibility to other STIs, including HIV.
“The major issue with chlamydia is the long-term consequences,” explained Professor Shattock. “It is very treatable if identified, but as many people don’t have symptoms it can be missed, and the biggest problem is that it can go on to cause infertility in women.”
He added: “One of the problems we see with current efforts to treat chlamydia is that despite a very big screening, test and treat programme, people get repeatedly re-infected. If you could introduce a protective vaccine, you could break that cycle.”
Encouraging early results
In the latest trial, researchers compared two different formulations of the new vaccine to examine which would perform better. The 35 women not infected with chlamydia included in the trial were randomly assigned to three different groups: 15 participants received the vaccine with liposomes, 15 received the vaccine with aluminium hydroxide, and 5 received saline solution (placebo).
In total, participants received five vaccinations with three intramuscular injections in the arm over several months, followed by two intranasal boosts.
Both formulations of the vaccine provoked an immune response in 100% of participants, whereas no participants in the placebo group achieved an immune response.
Although both formulations of the vaccine were found to provoke an immune response, the added liposomes consistently performed better and produced more antibodies, so the authors suggest this formulation should be pursued for further clinical development.
The full findings are published in the journal The Lancet Infectious Diseases. The group is now planning phase 2 trials.
UK risks being ‘left behind’
The research was made possible through grants from the European Commission. Professor Shattock raised concerns about the future of such international collaborations and whether UK institutions can maintain their leading role in vaccine research.
“Increasingly vaccine development requires multiple partners,” said Professor Shattock. “We have a wealth of world-leading expertise in the UK, with our scientists working to tackle infections, and to discover and develop new vaccines. But if we are no longer part of that European network we may be left behind.
“It’s not just about the funding, it’s about being part of these larger projects that bring together companies and academics and a much wider portfolio of experience, technology and expertise to solve global health problems.”
The Latest on: Chlamydia
via Google News
The Latest on: Chlamydia
- BRIEF-Eurocine Vaccines: Final Results From Preclinical Study With Chlamydia Vaccineon May 6, 2020 at 11:35 pm
* STUDY SHOWS THE VACCINE IS VERY IMMUNOGENIC IN BOTH LOW AND HIGH DOSE Source text: cisn.co/2YJj9w6 Further company coverage: (Gdansk Newsroom) Our Standards:The Thomson Reuters Trust Principles.
- STD Testing Rates, Service Receipt Among HIV-Positive MSM Remain Lowon May 4, 2020 at 2:04 pm
The CDC recommends regular testing for bacterial sexually transmitted diseases (STDs) among all sexually active gay, bisexual, and other men who have sex with men (MSM) because th ...
- STD rates rising in Michigan, but silver lining is increased testingon May 4, 2020 at 11:00 am
Numbers always tell the story, and when it comes to sexually transmitted diseases in Michigan, those numbers are on the rise.
- Inside Monroe County's COVID-19 contact tracing teamon May 4, 2020 at 5:36 am
This team is containing the spread of COVID-19 by identifying and isolating people who been in contact with a person who tested positive.
- Horrified Corrie fans react as Yasmeen is diagnosed with Chlamydia - but there was a satisfying twiston April 27, 2020 at 1:16 pm
Yasmeen has been feeling under the weather so made an appointment with the GP. But she was reeling to be told that she had tested positive for Chlamydia. As we all know, Yasmeen has caught the ...
- Corrie fans disgusted as Geoff gives Yasmeen chlamydia before sick twiston April 27, 2020 at 12:05 pm
Coronation Street fans were furious as abusive husband Geoff gave Yasmeen an STI after cheating on her with a prostitute, and his reaction when she told him beggars belief ...
- Coronation Street fans horrified as Geoff blames Yasmeen for getting chlamydia and calls her a ‘disease-ridden old tart’on April 27, 2020 at 11:56 am
CORONATION Street viewers were left horrified tonight as Geoff Metcalfe blamed Yasmeen Nazir for giving him chlamydia- and slammed her as a “disease-ridden old tart”. The domestic ...
- Coronation Street horror as Geoff forces Yasmeen into sex despite her being in pain with chlamydiaon April 24, 2020 at 12:10 pm
CORONATION Street fans are horrified after Geoff Metcalfe forced Yasmeen into sex – despite her being in obvious pain. The abuser – who is played by actor Ian Bartholomew in the ITV ...
- Chlamydia Diagnostic Testing Market 2020 Analysis Research and Development Forecast by 2026on April 22, 2020 at 4:34 am
A recent report provides crucial insights along with application based and forecast information in the Global Chlamydia Diagnostic Testing Market. The report provides a comprehensive analysis of key ...
- Chlamydia Diagnosis and Treatment Market By Development, Trends, Investigation 2020 And Forecast To 2026on April 21, 2020 at 7:09 am
Apr 21, 2020 (Profound via COMTEX) -- A recent report provides crucial insights along with application based and forecast information in the Global Chlamydia Diagnosis and Treatment Market.
via Bing News